Ibrance Resources

Downloads and Support

Resources To Support IBRANCE® (palbociclib) Therapy

Patient Brochure
Patient brochure
Patient Brochure
File Download

Want a comprehensive overview of IBRANCE? Download and print out this brochure.

Caregiver Guide
Caregiver guide
Caregiver Guide
File Download

Download this guide for tips and information that may help you care for your loved one and yourself.

Doctor Discussion Guides
Doctor discussion guide for treatment for a certain type of MBC
Doctor Discussion Guides

Already on IBRANCE? Print out this guide to have a productive discussion at your next appointment.

Considering IBRANCE? Print out this guide to start a conversation with your doctor.

Dosing Tracker For IBRANCE And An Aromatase Inhibitor
Dosing tracker for combination therapy
Dosing Tracker For IBRANCE And An Aromatase Inhibitor

Easily track your IBRANCE and aromatase inhibitor doses by downloading this tracker.

Dosing Tracker For IBRANCE And Fulvestrant
Dosing tracker for treatment for a certain type of MBC
Dosing Tracker For IBRANCE And Fulvestrant

Easily track your IBRANCE and fulvestrant doses by downloading this tracker.

Pfizer Oncology Together logo

Support Beyond Treatment

At Pfizer Oncology Together, we’re here to help. Our Care Champions will help you get personalized support—all in one place.* Whether it’s answers to questions or treatment and financial resources, we’re here to offer assistance when you need it most.

Financial SUPPORT

Find options to help cover the cost of your medicine—regardless of your insurance coverage.


Get guidance on living with cancer, including tips on lifestyle, nutrition, talking with loved ones, and IBRANCE Answers.

CUSTOM check-ins

Schedule check-ins that work around you—offering support when you need it and want it.


Connect to local, community, and patient outreach programs that offer comfort and support.


Learn about local programs that offer help with lodging and transportation while on treatment.

Workplace guidance

Receive tools and support to help you prepare for leaving or returning to work after being diagnosed.

*Some services are provided through independent third-party patient advocacy organizations.

Living With Metastatic Breast Cancer Takes Support

For patients going through a metastatic breast cancer diagnosis and for their caregivers, IBRANCE is here to help. IBRANCE offers a variety of resources with information about treatment, tips for emotional well-being, guides to dosing management, and more. Download the tools below for support now and throughout therapy.



Resources for IBRANCE® (palbociclib) Capsules | Safety Info
See risks and benefits of IBRANCE. Find downloadable resources to help support your IBRANCE® (palbociclib) capsules therapy.
Get To Know Women Taking IBRANCE

MBC Together Is Here For You And Your Loved Ones

A diagnosis of metastatic breast cancer isn’t easy, and it isn’t something you have to face alone. A strong support system can help you in your fight against MBC. MBC Together is here for IBRANCE® (palbociclib) patients and their loved ones, to help them find support and resources. Share in the experience of women who understand what you’re going through. Get inspired by their stories and learn how they don’t allow their diagnosis to define them.

Visit MBC Together

Meet Patti

Ambassadors were asked to share their personal stories about IBRANCE. All content was accurate at the time of publication and may have since changed.

Women with MBC Taking IBRANCE® (palbociclib) Capsules | Safety Info
See risks and benefits. Visit MBC Together and find support and stories from women taking IBRANCE® (palbociclib) capsules for metastatic breast cancer.

Frequently Asked Questions

IBRANCE Resources - FAQs - Accordion

IBRANCE is a prescription medicine used to treat hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer that has spread to other parts of the body (metastatic) in combination with:

  • an aromatase inhibitor as the first hormonal based therapy in women who have gone through menopause, or
  • fulvestrant in women with disease progression following hormonal therapy.

Talk to your healthcare team to see if IBRANCE is right for you.


IBRANCE may cause serious side effects, including:

Low white blood cell counts (neutropenia). Low white blood cell counts are very common when taking IBRANCE and may cause serious infections that can lead to death. Your doctor should check your white blood cell counts before and during treatment.

If you develop low white blood cell counts during treatment with IBRANCE, your doctor may stop your treatment, decrease your dose, or may tell you to wait to begin your treatment cycle. Tell your doctor right away if you have signs and symptoms of low white blood cell counts or infections such as fever and chills.

For more information, see side effects.


Before you take IBRANCE, tell your doctor if you:

  • have fever, chills, or any other signs or symptoms of infection.
  • have liver or kidney problems.
  • have any other medical conditions.
  • are pregnant or plan to become pregnant; IBRANCE can harm your unborn baby.
    • Females who are able to become pregnant and who take IBRANCE should use effective birth control during treatment and for at least 3 weeks after stopping IBRANCE.
    • Males who are taking IBRANCE and have female partners who can become pregnant should use effective birth control during treatment with IBRANCE and for 3 months after the final dose of IBRANCE.
  • are breastfeeding or plan to breastfeed; it is not known if IBRANCE passes into your breast milk. You and your doctor should decide if you will take IBRANCE or breastfeed. You should not do both.


Dosing for IBRANCE along with a hormonal therapy will be prescribed by your healthcare team.

Find IBRANCE and aromatase inhibitor dosing information here.

Find IBRANCE and fulvestrant dosing information here.


Yes. To monitor your side effects, your healthcare team will give you a blood test to check your complete blood cell count before you start taking IBRANCE at the beginning of every cycle.

Additionally, for the first 2 treatment cycles, you'll need a complete blood cell count done on day 15 as well. Make sure to tell your healthcare team which day you start your first and second cycles, so they can schedule your day 15 appointment at the right time.

If your results indicate low white blood cell counts (neutropenia), your healthcare team may temporarily hold or adjust your dose. It's not uncommon to have doses modified throughout treatment. Be sure to follow your dosing schedule exactly as your healthcare team prescribes.


Find side effect information and tips here.

Alopecia (hair thinning or hair loss) is a common side effect of IBRANCE. The majority of women who experienced alopecia had hair thinning rather than hair loss.


Hormone receptor-positive (HR+) is a subtype of breast cancer that includes both ER+ and/or PR+ subtypes and grows in response to 2 different hormones—estrogen and/or progesterone. If your cancer grows in response to the hormone estrogen, your cancer could also be called estrogen receptor-positive (ER+). If your cancer grows in response to the hormone progesterone, it could be called progesterone receptor-positive (PR+).


Yes, the Pfizer Oncology Together Co-Pay Savings Program may help eligible, commercially insured patients save on out-of-pocket costs, and Pfizer Oncology Together can connect patients who are uninsured, under-insured or have government insurance with services to help you pay for your IBRANCE prescription.


A CDK 4/6 inhibitor is a type of treatment that works to put the brakes on cell growth and division by preventing certain proteins (called CDK 4 and CDK 6) from telling the cell that it needs to grow and divide.

IBRANCE is in a class of drugs called CDK 4/6 inhibitors that work to put the brakes on cell growth and division in both healthy and cancer cells. This helps slow the progression of cancer, but it can also cause side effects, some of which are serious. Please see the Important Safety Information to learn more.


No. Breast cancer can spread regardless of treatment or preventative measures taken.

Yes. Check out our resources here.

FAQs for IBRANCE® (palbociclib) Capsules | Safety Info
See risks and benefits of IBRANCE. Find answers to common questions about IBRANCE® (palbociclib) capsules.